Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Sabater Lleal, Maria ^a   Mälarstig, Anders ^b   Folkersen, Lasse ^a,n   Artigas, María Soler ^c,d   Baldassarre, Damiano ^e,f   Kavousi, Maryam ^g   Almgren, Peter ^h   Veglia, Fabrizio ^f   Brusselle, Guy ^g,i   Hofman, Albert ^g   Engström, Gunnar ^h   Franco, Oscar H ^g   Melander, Olle ^h,j   Paulsson Berne, Gabrielle ^a   Watkins, Hugh ^k   Eriksson, Per ^a   Humphries, Steve E ^l   Tremoli, Elena ^e,f   De Faire, Ulf ^m   Tobin, Martin D ^c,d   Hamsten, Anders ^a   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d National Institute for Health Research Leicester Respiratory Biomedical Research Unit Glenfield Hospital ^*  (United Kingdom)

^e UNIVERSITY OF MILAN   (Italy)

^f CENTRO CARDIOLOGICO MONZINO   (Italy)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h LUND UNIVERSITY   (Sweden)

ⁱ Inspectorate for Health Care   (Netherlands)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ NOVO NORDISK A S   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POTASSIUM CHANNEL KCNE2; SEROTONIN RECEPTOR;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HTR4 GENE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPIROMETRY; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; LUNG; LUNG VENTILATION; MALE; PHYSIOLOGY; RISK;

ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY VENTILATION; RISK; SPIROMETRY;

EID: 84905438148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104082     Document Type: Article

References (35)

1. Silverman EK, Speizer FE (1996) Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 80: 501-522. (Pubitemid 26146094)
2. Wright JL, Hobson JE, Wiggs B, Pare PD, Hogg JC (1988) Airway inflammation and peribronchiolar attachments in the lungs of nonsmokers, current and exsmokers. Lung 166: 277-286.
3. Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59: 574-580. (Pubitemid 38901515)
4. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, et al. (2010) An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 693-718.
5. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J (2006) Developing COPD: a 25 year follow up study of the general population. Thorax 61: 935-939. (Pubitemid 44787161)
6. Silverman EK (2006) Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc 3: 405-408.
7. Castaldi PJ, Cho MH, Litonjua AA, Bakke P, Gulsvik A, et al. (2011) The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol 45: 1147-1153.
8. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, et al. (2010) Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42: 200-202.
9. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, et al. (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 5: e1000421.
10. Soler Artigas M, Wain LV, Repapi E, Obeidat M, Sayers I, et al. (2011) Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med 184: 786-795.
11. Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, et al. (2012) Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 186: 622-632.
12. Mullerova H, Agusti A, Erqou S, Mapel DW (2013) Cardiovascular Comorbidity in COPD: Systematic Literature Review. Chest 144: 1163-1178.
13. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, et al. (2010) Genome-wide association study identifies five loci associated with lung function. Nat Genet 42: 36-44.
14. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, et al. (2011) Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43: 1082-1090.
15. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, et al. (2010) Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 42: 45-52.
16. Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, et al. (2009) A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 5: e1000429.
17. Baldassarre D, Hamsten A, Veglia F, de Faire U, Humphries SE, et al. (2012) Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study. J Am Coll Cardiol 60: 1489-1499.
18. Baldassarre D, Veglia F, Hamsten A, Humphries SE, Rauramaa R, et al. Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler Thromb Vasc Biol 33: 2273-2279.
19. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939.
20. Gertow K, Sennblad B, Strawbridge RJ, Ohrvik J, Zabaneh D, et al. (2012) Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet 5: 656-665.
21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. (Pubitemid 47330214)
22. Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190-2191.
23. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, et al. (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 361: 2518-2528.
24. Peden J, Hopewell JC, Saleheen D (2011) A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 43: 339-344.
25. Folkersen L, van't Hooft F, Chernogubova E, Agardh HE, Hansson GK, et al. (2010) Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet 3: 365-373.
26. Myocardial Infarction Genetics C, Kathiresan S, Voight BF, Purcell S, Musunuru K, et al. (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41: 334-341.
27. Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442. (Pubitemid 27212192)
28. Maclay JD, McAllister DA, Macnee W (2007) Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 12: 634-641. (Pubitemid 47414891)
29. Bhatt SP, Dransfield MT (2013) Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res.
30. Crawford DC, Carlson CS, Rieder MJ, Carrington DP, Yi Q, et al. (2004) Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am J Hum Genet 74: 610-622. (Pubitemid 38420092)
31. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, et al. (1999) Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 30: 841-850. (Pubitemid 29156378)
32. Schroeder EB, Welch VL, Evans GW, Heiss G (2005) Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis 180: 367-373. (Pubitemid 41072908)
33. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, et al. (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97: 175-187.
34. Tang DD (2009) p130 Crk-associated substrate (CAS) in vascular smooth muscle. J Cardiovasc Pharmacol Ther 14: 89-98.
35. Tikhmyanova N, Little JL, Golemis EA (2010) CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 67: 1025-1048.